Tricida TCDA
$ 0.11
0.0%
Quarterly report 2022-Q3
added 11-14-2022
Country |
USA |
IPO year |
2018 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Gerrit Klaerner |
Employees in the company |
157 |
Shares |
51.3 M |
Market Cap[1] |
$ 3.25 M |
EBITDA (LTM) |
$ -113 M |
P/E (LTM) |
-0.05 |
P/S (LTM) |
- |
EPS (LTM) |
-2.23 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.